FloBio
PrivateLast Round
Grant
May 1, 2022
Total Funding Raised
$1.05M
Company Overview
FloBio operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a Grant round in May 2022.
FloBio is a healthcare company that develops a novel fluidic-based point-of-care diagnostic platform for assessing blood clotting and thrombotic risk in emergency and critical care settings.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Healthcare Analytics, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FloBio Comparables
Compare FloBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stasys Medical Corporation | 86% | |
| Sienco, Inc. | 83% | |
| Perosphere Technologies Inc. | 83% |
For institutional investors. Book with your work email.
FloBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2022 | ||||
| Seed | Jan 19, 2021 | ||||
| Grant | Nov 1, 2020 | ||||
| Grant | Aug 1, 2020 | ||||
| Grant | Sep 1, 2019 | ||||
Grant | May 2, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
FloBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benjamin Franklin Technology Partners | Seed |
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Pennsylvania Pediatric Medical Device Consortium | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors increased 198% MoM, reaching 2K.
- Apr 5, 2026
Monthly visitors grew 47% MoM.
For institutional investors. Book with your work email.
FloBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FloBio's valuation, stock price, and market status.
Is FloBio a public or private company?
FloBio is a private company.
What is the current stock price of FloBio?
FloBio is a private company, so its shares have no public market price. Caplight tracks FloBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FloBio worth (valuation)?
Valuation information for FloBio is not publicly available.
Can I buy FloBio stock?
FloBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FloBio's last funding round?
FloBio's most recent funding round was Grant on May 1, 2022.
Who are the main investors in FloBio?
Key investors in FloBio include Benjamin Franklin Technology Partners, NIH RADx, National Heart, Lung, and Blood Institute, Pennsylvania Pediatric Medical Device Consortium, National Science Foundation.
Will FloBio IPO soon?
No public IPO plans have been announced for FloBio.
How can I track FloBio secondary market activity?
Caplight tracks bids, offers, and trades in FloBio's shares on secondary markets.